Terns Pharmaceuticals stock jumps 10% as JPM conference puts TERN-701 back on the map
New York, Jan 14, 2026, 12:57 EST — Regular session Terns Pharmaceuticals (TERN.O) shares jumped over 10% Wednesday, fueled by the company’s newest conference update on its lead cancer drug. By midday, the stock had risen 10.4% to $38.03, after trading in a range from $34.05 to $38.35. The shift coincides with biotech investors flocking to the annual J.P. Morgan…